Empowering NY Transportation Providers: MediRoutes Introduces Streamlined Processes and Real-time Solutions with MAS Integration

MediRoutes Logo …

WASHINGTON, July 13, 2023 (Newswire.com)
–
The Calorie Control Council, an international association representing the low-calorie food and beverage industry, supports the World Health Organization’s (WHO) findings regarding the safety of aspartame, that aligns with more than 90 credible global scientific and regulatory food agencies that have extensively reviewed aspartame and determined it is safe.

JECFA is charged by the WHO to evaluate ingredients like aspartame and determine their safety. After conducting a thorough re-assessment, JECFA concluded there are no concerns regarding adverse effects of consuming aspartame at current levels and reaffirmed the acceptable daily intake level (ADI), underscoring its previous conclusion that aspartame is safe.  

“The JECFA ruling not only confirms the four decades of science concluding aspartame is safe but also provides real-life ‎context around the safe consumption of this ingredient,” said Robert Rankin, President, Calorie Control Council. “In order to reach JECFA’s conservative ADI estimates, the average 150 lb. person would need to consume about 14 12-oz cans of diet beverages or about 74 packets of aspartame-containing tabletop sweetener every day over the course of their life to raise any safety concern. Obviously, that level of consumption is not realistic, recommended, nor is it ‎aligned with the intended use of these ingredients.”  

“Consumers have a strong desire for reliable and science-based information and JECFA’s review reaffirms the overwhelming body of evidence that confirms aspartame is safe. To assert otherwise is misleading, inaccurate, and fearmongering to the nearly 540 million people globally living with diabetes and millions of others managing their body weight who rely on and/or chose products that contain low- and no-calorie sweeteners such as aspartame,” continued Rankin.  

Consumers who look to low- and no-calorie sweeteners – including aspartame – for managing sugar and calorie reduction can continue to feel comfortable knowing it has been proven a safe and effective choice based on the findings of global health organizations which review the relevant scientific evidence regularly. 

### 

About the Calorie Control Council

The Calorie Control Council, established in 1966, is an international association representing the low- and reduced-calorie food and beverage industry. Today it represents manufacturers and suppliers of low-, no- and reduced-calorie foods and beverages, including manufacturers and suppliers of more than two dozen different alternative sweeteners, dietary fibers, and other low-calorie, dietary ingredients. More at caloriecontrol.org.  

Contact Information:

Robin Applebaum

[email protected]

678.303.2980

Original Source:

The Calorie Control Council Comments on the World Health Organization’s Review of the Safety of Aspartame

Neuma Develops Disinfecting Cap That Mechanically Cannot Be Used More Than Once

Neuma Innovations
Neuma Innovations Logo

PALO ALTO, Calif., July 11, 2023 (Newswire.com)
–
Neuma Innovations^TM, creator of the original Neuma Clamp^TM that deters and detects central line abuse by IVDU (intravenous drug using) patients, today announced the development of a new disinfecting cap that prevents reuse and is tamper-evident.

“We’ve been working closely with infusion professionals since 2015 to design solutions to problems associated with central line blood infections. We learned that about 28% of caregivers use the same disinfecting cap more than once, which obviously compromises the caps’ effectiveness. Our team set out to design a simple device that, because it can’t be reattached after the first use, dramatically improves compliance,” said Hal Rucker, President of Neuma Innovations. “The added benefit is that our cap also protects lines from patients who use their lines to self-inject illicit drugs.”

NO CHANGES TO WORKFLOWS

The Neuma Cap^TM disinfects, approaches 100% compliance, minimizes the harmful consequences of abuse by IVDU patients, facilitates the discharge to SNF and OPAT care, and fits seamlessly into existing workflows.

“The Neuma Cap genuinely ensures the enforcement of single-use protocols while its price point remains on par with comparable alternatives,” said Amy Duncan, Director of Business Development. “The ingenuity of Neuma’s product lies in its indistinguishable resemblance to conventional disinfecting caps without requiring any changes in workflow. From the perspective of clinicians, the Neuma Cap is a frictionless industry disrupter for optimal patient care.”

About Neuma Innovations

Neuma Innovations develops simple medical products to solve complex medical problems.

Neuma Caps and Neuma Clamps are patent-protected. Neuma, Neuma Innovations, Neuma Clamp, Neuma Central Line Protection Clamp, Neuma Cap, and Neuma Disinfecting Cap are trademarks of Neuma Innovations, LLC. All Rights Reserved. 

Copyright © 2023 Neuma Innovations LLC

Contact Information:

Hal Rucker

President

[email protected]

(650) 759-1203

Original Source:

Neuma Innovations’ Single-Use IV Disinfecting Cap Improves CLABSI Prevention and Deters Central Line Abuse by IVDU Patients

Enhanced Revenue Integrity offering strengthens audits, denials management, clinical documentation improvement solutions, and coder education to improve healthcare systems’ financial wellness.

AQuity Logo
AQuity Logo

CARY, N.C., July 11, 2023 (Newswire.com)
–
AQuity Solutions, an industry-leading, tech-enabled Clinical Documentation Capture, Medical Coding, and Mid-Revenue Cycle solution supplier for healthcare provider organizations, announced the launch of its Revenue Integrity portfolio. The solutions include Claim Denial & Appeals Management, Coding Audits & Record Analysis, Claim & Edit Remediation, Clinical Documentation Improvement, and Medical Coding Education & Training services.

The highly customizable set of offerings drive revenue cycle quality and productivity, allowing hospitals, clinics, and physician practices to meet and exceed their quality benchmarks through strengthened documentation capture details, improved coding accuracy, and payer-specific claim preparations to solidify accurate revenue while ensuring compliance. AQuity’s unique consultative approach helps manage risks and improve quality.

“Our Revenue Integrity solutions positively impact our client’s financial success through our team of experienced consultants in over 30 specialties, including Cardiovascular Interventional Radiology (CVIR) and other complex sub-specialties,” noted Susan Gatehouse, AQuity’s VP of Revenue Integrity and RHIT, CCS, and ICD-10 CM/PCS AHIMA Certified Trainer. “AQuity drives revenue success by applying detailed coding, charging, billing assessments, claim auditing, denial management, and multifaceted education strategies.” 

“With increased financial pressures and growing regulatory scrutiny for all provider organizations, AQuity’s Revenue Integrity solutions ensure compliance and financial performance,” added Kashyap Joshi, AQuity’s CEO. “Our commitment to expand our Revenue Integrity offerings is in direct response to market needs and our commitment to help AQuity clients overcome their most challenging issues related to the revenue cycle.” 

About AQuity

Headquartered in Cary, NC, AQuity provides solutions for 21 of the Top 25 and over half of the Top 250 Health Systems in the United States. AQuity employs over 7,500 virtual scribe and medical transcription document capture specialists, medical coders, and revenue integrity specialists in multiple specialties across the United States, India, Australia, Canada, and the U.K. With over 40 years of experience in solutions for healthcare, AQuity is recognized year after year by KLAS and Black Book as a leading vendor in multiple disciplines. AQuity is privately held. https://aquitysolutions.com. 

Contact Information:

Dale Kivi

Senior Director of Communications

[email protected]

804.339.9017

Original Source:

AQuity Broadens Its Portfolio With Launch of Revenue Integrity Solutions

The merger will combine URA’s exclusive technology and expertise with Diamond Institute’s best fertility specialists to create one of the strongest networks of fertility clinics in northern New Jersey and New York.

Logo
URA | Diamond logo

HASBROUCK HEIGHTS, N.J., July 11, 2023 (Newswire.com)
–
University Reproductive Associates (URA) and Diamond Institute today announced a merger that will create one of the most technologically advanced networks of fertility clinics in northern New Jersey and New York, as well as the most personalized. Both URA and Diamond Institute have built their successes on excellence in care, from initial evaluation to guidance on financial assistance. That care will now be available at six offices in six counties. New Jersey offices: Hasbrouck Heights in Bergen County, Wayne in Passaic County, Millburn in Essex County, Denville in Morris County and Hoboken in Hudson County. New York office: Goshen in Orange County.

According to Peter McGovern, M.D., a founding physician at URA, the merger will result in a new level of fertility care and solutions as more treatment options will be available, delivered with the one-on-one, personal care for which both organizations are known among their patients. URA is already the first and only fertility clinic network in New Jersey to offer the LifeAire in-duct air purification system, leading to a 15%-20% higher chance of successful implantation and pregnancy. URA is also the only network of fertility clinics in New Jersey to offer robotic surgery using the da Vinci^® Surgical System. 

From Diamond Institute, the merger will bring to URA two leading fertility specialists in New Jersey, Dr. Matan Yemini and Dr. Ndidiamaka Onwubalili. Dr. Yemeni brings 30 years of experience focusing interest, practice and research on the spectrum of issues associated with reproductive endocrinology and infertility treatment. Dr. Yemeni is bilingual, also speaking Hebrew. Dr. Onwubalili, aka “Dr. O,” is board-certified in Obstetrics and Gynecology and Reproductive Endocrinology. She is a Fellow of the American Congress of Obstetricians, and her clinical and research focus includes polycystic ovarian syndrome, fertility preservation, uterine fibroids, and minimally invasive surgery.

“There’s no doubt that URA provides families-to-be with higher chances than most fertility clinics through technology. Combined with the warm, personal care that’s already our standard with each and every couple, I think the merger will create something even better than the sum of its parts,” Dr. Onwubalili said.

Contact Information:

Leonard Schwartz

Practice Manager

[email protected]

201-288-6330

Original Source:

University Reproductive Associates Merges With Diamond Institute to Create a Network of Fertility Clinics in Both Northern New Jersey and New York

Specialty pharmaceutical research company celebrates the launch of a new service offering and with it, a brand refresh.

Humonix Logo New company …

Smile’s new addition to its privacy certification is the best of both worlds—compliance and data protection.

TORONTO, July 11, 2023 (Newswire.com)
–
Smile Digital Health (Smile), a leading FHIR® health data fabric and exchange solutions provider, announced today that it has successfully implemented ISO 27018:2019, an international guideline focused on safeguarding personally identifiable information (PII) in cloud computing. 

ISO 27018 is entirely voluntary; however, Smile chose to extend its current certification of ISO 27001 with ISO 27018 to ensure its privacy information management system meets the most comprehensive guidelines when it comes to collecting, processing, storing, sharing and destroying PII and protected health information (PHI) data in the Cloud. Although the focus of ISO 27018 is data protection, it also offers guidelines for the General Data Protection Regulation (GDPR), the California Consumer Privacy Act (CCPA) and other regulatory compliance. Along with PII handling, ISO 27018 provides guidelines for third-party management for subcontractors and security incident management.

ISO 27018 certification is particularly relevant for customers of Smile’s Cloud-based Managed Services offering. Smile Managed Services is an end-to-end service package encompassing FHIR-based implementation, maintenance, security and support for cloud or hybrid-deployed Health Data Fabric (HDF) solutions. Managed Services customers can trust that their data is safeguarded and won’t be used for any purposes other than those that they give consent for based on the ISO 27018 controls, objectives and guidelines.

“ISO 27018 ensures the data our Managed Services customers store, share and process in the Cloud is handled based on the highest level of privacy standards,” said George Rollins, President, Smile Digital Health. “I’m proud that we can offer solutions and support that provide the security our customers look to us for. Our privacy information management system and all that our team has been able to accomplish in terms of certifications is truly impressive.”

“It’s important for us as we continue to grow our product and service offerings to ensure we are always operating with the highest standards when it comes to security and privacy. Our Managed Services solution made implementing ISO 27018 the obvious next step for us in terms of PII protection in the Cloud,” said Luis de Barros, Chief Privacy and Security Officer, Smile Digital Health.

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data fabric and integration platform fuels healthcare’s digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate, and meaningfully share health information to power digital transformation. We prepare healthcare providers, payers, researchers, and life sciences organizations for a connected future beyond legacy systems, adding new value through the intelligent use of information, and ultimately delivering better patient outcomes. For more information, visit SmileDigitalHealth.com. 

Contact Information:

Victoria Valladolid

Director of Marketing, Smile Digital Health

[email protected]

(877) 537-3343 x 728

Original Source:

Smile Digital Health Achieves ISO 27018 Certification

Roche and Somatix Teams at Beta-i
The Roche and Somatix teams gather together at Beta-i’s \”Innovation in Dementia\” event.

NEW YORK, July 11, 2023 (Newswire.com)
–
Somatix leadership presented the results of its brand-new medication compliance and hydration capabilities that were trained and launched in Portuguese hospitals and clinics as part of the Building Tomorrow Together – Innovation in Dementia Program with Roche Pharmaceuticals, Multicare, and Beta-i Collaborative Innovation. The project was part of an open innovation initiative powered by Beta-i, in which four startups, including Somatix, were selected to conduct their pilots in public or private institutions in Portugal. Somatix is honored to be part of this project to improve the quality of life of patients with dementia.

Using its unique artificial intelligence-enabled technology, Somatix is able to provide powerful clinical insights from wearables worn by patients with early to mid-stage dementia, including hydration, falls and medication compliance. Dehydration and missed medication dosages are potentially preventable events that otherwise lead to injury and illness. With the combination of remote monitoring, telehealth, and Somatix’s SafeBeing^TM platform, the goal is to keep these patients safer and healthier while preserving their independence, and to improve their quality of life either at home or in an independent living facility. Partnering with Roche and two major health providers in Portugal, Campus Neurologico Senior (cnscampus.com) and CUF (cuf.pt), Somatix demonstrated the first successful clinical use of its ground-breaking medication compliance feature.

Dr. Charles Herman, CEO of Somatix, commented, “Somatix’s AI-powered Remote Patient Monitoring (RPM) platform for healthcare providers uniquely uses wearable-enabled gesture detection to yield powerful clinical insights to improve patient outcomes with the help of strategic partners like Roche and Multicare, our sponsors; CNS and CUF, our healthcare provider partners; and Beta-i, the open innovation program developer; bringing groundbreaking technology to the aging population in Europe. We also worked closely with our ecosystem partner, Amazon Web Services, to build our first cloud-based server in Europe.”

“Somatix is happy to report that the medication compliance feature was accurately able to detect pills taken and missed with over 70% accuracy. Based on the experience with Roche and its partners, we have already found opportunities to further improve the accuracy of our medication intake algorithm and plan to reach close to 90% accuracy in the next phase of our project. We also observed close to 95% accuracy in detecting the amount of fluid consumed over a day,” says Dr. Amit Sawant, COO of Somatix.

Somatix and Roche plan to expand the partnership later this year, bringing Somatix’s platform to more outpatients with early and mid-stage dementia in an effort to keep them safer and healthier in their own environments.

Contact Information:

Jessica Bradley

Director of Sales

[email protected]

Original Source:

Somatix and Roche Launch an Only-of-Its-Kind Medication Compliance Capability Using AI-Enabled Wearable Technology

AMD Global Telemedicine AMD company logo

CHELMSFORD, Mass., July 11, 2023 (Newswire.com)
–
AMD Global Telemedicine Inc. (AMD), a renowned global leade…

Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital Whiteboards

Vizzia Logo Vizzia Technologies

ATLANTA,…